Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

Autor: Mirza, Mansoor R., Benigno, B., Dørum, A., Mahner, S., Bessette, P., Barceló, I. Bover, Berton-Rigaud, D., Ledermann, J.A., Rimel, B.J., Herrstedt, J., Lau, S., du Bois, A., Herráez, A. Casado, Kalbacher, E., Buscema, J., Lorusso, D., Vergote, I., Levy, T., Wang, P., de Jong, F.A., Gupta, D., Matulonis, U.A.

Publikováno v: In Gynecologic Oncology November 2020 159(2):442-448

Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib:Results from the ENGOT-OV16/NOVA trial

Autor: Oza, A. M., Matulonis, U. A., Malander, S., Sehouli, J., del Campo, J. M., Berthon-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, Bente, Tinker, A. V., Hilpert, F., Palacio Vázquez, I., D’hondt, V., Benigno, B., Provencher, D. M., Buscema, J., Hudgens, S., Agarwal, S., Mirza, M. R.

Publikováno v: Oza, A M, Matulonis, U A, Malander, S, Sehouli, J, del Campo, J M, Berthon-Rigaud, D, Banerjee, S, Scambia, G, Berek, J S, Lund, B, Tinker, A V, Hilpert, F, Palacio Vázquez, I, D’hondt, V, Benigno, B, Provencher, D M, Buscema, J, Hudgens, S, Agarwal, S & Mirza, M R 2017, ' Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib : Results from the ENGOT-OV16/NOVA trial ', Annals of Oncology, vol. 28, no. Suppl. 5, 930O, pp. 330 . < http://www.esmo.org/content/download/117241/2057634/file/ESMO-2017-Abstract-Book.pdf >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1266::d0344721486d8bf7d17c53dd79e25834
https://vbn.aau.dk/da/publications/53eed913-7b16-4b63-ba84-495311040d8e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evidence for the Importance of Post-transcriptional Regulatorychanges in ovarian cancer metastasis and the contribution of miRNAs

Autor: Zhang, M., Matyunina, L., Walker, L., Chen, W., Xiao, H., Benigno, B., Wu, R., McDonald, J.

Publikováno v: In Gynecologic Oncology October 2017 147(1):211-212

930O - Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA Trial

Autor: Oza, A.M., Matulonis, U.A., Malander, S., Sehouli, J., del Campo, J.M., Berthon-Rigaud, D., Banerjee, S., Scambia, G., Berek, J.S., Lund, B., Tinker, A.V., Hilpert, F., Palacio Vázquez, I., D’Hondt, V., Benigno, B., Provencher, D.M., Buscema, J., Hudgens, S., Agarwal, S., Mirza, M.R.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v330-v330